Profile
Yael Hayon formerly worked at Stem Cell Medicine Ltd., as Manager-Research & Development from 2014 to 2016, Syqe Medical Ltd., as Vice President-Clinical Affairs, LogicBio Therapeutics, Inc., as Head-Research & Development from 2016 to 2020, and Protalix Biotherapeutics, Inc., as Vice President-Research & Development from 2020 to 2024.
Dr. Hayon received her graduate degree and doctorate degree from The Hebrew University of Jerusalem.
Former positions of Yael Hayon
| Companies | Position | End |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2024 |
| LOGICBIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
Stem Cell Medicine Ltd.
Stem Cell Medicine Ltd. Pharmaceuticals: OtherHealth Technology Provides therapeutic technology in combination with medication | Chief Tech/Sci/R&D Officer | 01/01/2016 |
Syqe Medical Ltd.
Syqe Medical Ltd. Medical SpecialtiesHealth Technology Develops metered-dosed cannabis inhaler | Corporate Officer/Principal | - |
Training of Yael Hayon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Stem Cell Medicine Ltd.
Stem Cell Medicine Ltd. Pharmaceuticals: OtherHealth Technology Provides therapeutic technology in combination with medication | Health Technology |
Syqe Medical Ltd.
Syqe Medical Ltd. Medical SpecialtiesHealth Technology Develops metered-dosed cannabis inhaler | Health Technology |
LogicBio Therapeutics, Inc.
LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
- Stock Market
- Insiders
- Yael Hayon
















